J Musculoskelet Neuronal Interact 21:142148 Cheng Y, Liu P, Xiang Q, Liang J, Chen H, Zhang H, Yang L (2022) Glucagon-like peptide-1 attenuates diabetes-associated osteoporosis in ZDF rat, possibly through the RAGE pathway
Semaglutide (Wegovy) is given once weekly, while liraglutide (Saxenda) requires daily administration
The only differences are the typical concentrations available and the standard dose ranges
Importantly, hemodynamic effects - modest reductions in heart rate (+2-4 bpm) and blood pressure decreases - are generally well tolerated and beneficial in this population
This combination approach allows lower doses of each component, potentially reducing side effects while maintaining efficacy
Coverage is required and generally available with prior authorization